Research has examined glutathione and its precursor N-acetyl cysteine (NAC) and found clinical benefit in treating peripheral artery disease 2 , Parkinsons disease 3 , fatty liver 4 , coronary reperfusion injury 5 , bipolar disorder 6-7 obsessive compulsive disorder 8 , schizophrenia 6,9,10 , addiction treatment 11-12 , autism 13 and flu prevention 14
Check 2: Confirm your prescribed dose
Dual-acting oral GLP-1s are not yet available, but they are expected in the future
Brain GSH concentrations and investigating heterogeneity Brain GSH did not differ in AD (pooled SMD [95%CI] = 0.07 [1.29, 1.43], p =0.6) and MCI (pooled SMD [95%CI] = 0.43 [1.19, 0.33], p =0.26) compared to healthy controls